|Day's Range||34.22 - 34.42|
|52 Week Range||25.25 - 36.82|
|PE Ratio (TTM)||24.53|
|Dividend & Yield||1.03 (3.00%)|
|1y Target Est||N/A|
We issued an updated research report on Alnylam Pharmaceuticals, Inc. (ALNY) on May 23, 2017.
Bioverativ stock popped Wednesday after the Biogen spinoff announced a $400 million acquisition of True North Therapeutics.
Looking for dividend stocks in the gene sequencing field? Check out General Electric, Roche, and Quest Diagnostics.